Neuromuscular Electrical Stimulation (NMES) in Patients With Intermittent Claudication
Paraules clau
Resum
Descripció
The circulation of blood around the body is dependent on effective pumping of the heart. Patients with claudication experience pain or discomfort in their legs usually during activity such as walking, which goes away at rest. Claudication is a symptom of peripheral arterial disease (PAD). If left untreated, patients can develop arterial insufficiency which can lead to various complications such as swelling, painful legs, reduced healing of injuries and the loss of limbs in extreme conditions.
PAD can be defined as a narrowing of the arteries reducing blood flow. It is most commonly due to atherosclerosis, and has associations with heart disease, stroke, and diabetes. Its incidence is estimated at 7-14% in the general population, increasing with age to about 20% in the over-seventies. It is associated with effects on mobility, skin condition and quality of life. Symptoms include pain in the legs on walking (intermittent claudication), pain at rest (particularly at night), gangrene, and limb loss. Management of PAD is based on encouraging exercise, and modification of risk factors such as smoking, high blood pressure, high cholesterol and diabetes.
In patients with PAD, exercise tolerance is often limited. Severe symptoms and disease can be treated by procedures such as balloon angioplasty, stenting or surgical bypass, but these procedures have risks. There also remains a percentage of patients who are not suitable for revascularisation, and have few options besides amputation available to them.
Some trials have shown that increasing the blood flow in the legs over time using medical devices (intermittent pneumatic compression, muscle stimulators), in addition to maximal medical and surgical therapy, can increase claudication distance, absolute walking distance, decrease rest pain, and reduce amputation rates. In our unit it has become apparent that there are an increasing number of medical devices available for circulatory support, either for use as an inpatient, out-patient, or a member of the general public. The supporting evidence for these is variable in scientific and clinical content or relevance, and requires clinical trials to evaluate further.
The device being used in this study, activates the pumping action of the leg muscles by providing neuromuscular electrical stimulation (NMES) to cause foot muscle contraction and relaxation. This squeezes blood back towards the heart, improving circulation.
The study will evaluate whether NMES using this device has the same beneficial effects in patients with intermittent claudication.
Dates
| Darrera verificació: | 07/31/2019 |
| Primer enviat: | 04/23/2015 |
| Inscripció estimada enviada: | 04/30/2015 |
| Publicat per primera vegada: | 05/05/2015 |
| Última actualització enviada: | 08/18/2019 |
| Publicació de l'última actualització: | 09/19/2019 |
| Data dels primers resultats enviats: | 08/18/2019 |
| Data dels primers resultats de control de qualitat enviats: | 08/18/2019 |
| Data dels primers resultats publicats: | 09/19/2019 |
| Data d'inici de l'estudi real: | 11/30/2014 |
| Data estimada de finalització primària: | 09/30/2015 |
| Data estimada de finalització de l’estudi: | 09/30/2015 |
Condició o malaltia
Intervenció / tractament
Device: Intervention
Fase
Grups de braços
| Braç | Intervenció / tractament |
|---|---|
| Experimental: Intervention Patients receiving neuromuscular electrical stimulation. | Device: Intervention Revitive IX neuromuscular electrical stimulation device will be given to all participants as per protocol. |
Criteris d'elegibilitat
| Edats elegibles per estudiar | 18 Years Per a 18 Years |
| Sexes elegibles per estudiar | All |
| Accepta voluntaris saludables | Sí |
| Criteris | Inclusion Criteria: - All ethnic groups, male or female above the age of 18 years. - Diagnosis of mild intermittent claudication - Be of non-childbearing potential; OR using adequate contraception and have a negative urine pregnancy test result within 24 hours if appropriate before using the study device. - Blood pressure currently under moderate control (< 160/100mmHg) - No current foot ulceration Exclusion Criteria: - Patients meeting any of the following criteria are to be excluded: - Has an unstable condition (eg, psychiatric disorder, a recent history of substance abuse) or otherwise thought to be unreliable or incapable of complying with the study protocol. - Has diabetes - Ankle Brachial Pressure Index > 0.9 - Has any metal implants - Pregnant - Has a cardiac pacemaker or defibrillator device - Has recent lower limb injury or lower back pain - Has current foot ulceration or other skin ulcers - Has foot deformities - Has any disorder that, in the opinion of the Investigator, might interfere with the conduct of the study. |
Resultat
Mesures de resultats primaris
1. Initial Walking Distance Measured by Treadmill [Change in baseline treadmill walking distance at 6 weeks]
2. Absolute Walking Distance Measured by Treadmill [Change in baseline treadmill walking distance at 6 weeks]
Mesures de resultats secundaris
1. Femoral Haemodynamics Measured by Femoral Artery Duplex Ultrasonography [Change in baseline femoral haemodynamics at 6 weeks]
2. Laser Doppler Flow Measured by Optical Laser [Change in baseline flowmetry at 6 weeks]
3. Symptomatic Scores by Questionnaire [Change in baseline questionnaire scores at 6 weeks]
4. Quality of Life Scores Measured by Questionnaire [Change in baseline quality of life at 6 weeks]
5. Urine Metabolic Profile [Change of profile at baseline and at 6 weeks]
6. Serum Metabolic Profile [Change of profile at baseline and 6 weeks]
